Pulmonx (LUNG)
(Delayed Data from NSDQ)
$9.82 USD
+0.44 (4.69%)
Updated May 3, 2024 04:00 PM ET
After-Market: $9.82 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum C VGM
Balance Sheet
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 117 | 141 | 180 | 232 | 28 |
Receivables | 12 | 9 | 7 | 4 | 6 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 17 | 15 | 16 | 11 | 6 |
Other Current Assets | 4 | 4 | 5 | 3 | 2 |
Total Current Assets | 150 | 169 | 208 | 250 | 41 |
Net Property & Equipment | 4 | 5 | 5 | 1 | 1 |
Investments & Advances | 17 | 11 | 11 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 2 |
Intangibles | 2 | 2 | 3 | 3 | 3 |
Deposits & Other Assets | 1 | 1 | 1 | 1 | 1 |
Total Assets | 178 | 194 | 235 | 264 | 54 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 2 | 2 | 1 | 3 |
Current Portion Long-Term Debt | 2 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 16 | 13 | 13 | 9 | 9 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 1 |
Total Current Liabilities | 23 | 18 | 18 | 13 | 14 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 35 | 17 | 17 | 17 | 15 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 1 | 1 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 59 | 40 | 42 | 38 | 36 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 205 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 527 | 503 | 483 | 467 | 22 |
Retained Earnings | -411 | -350 | -291 | -243 | -211 |
Other Equity | 3 | 2 | 2 | 2 | 1 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 118 | 154 | 193 | 226 | 18 |
Total Liabilities & Shareholder's Equity | 178 | 194 | 235 | 264 | 54 |
Total Common Equity | 118 | 154 | 193 | 226 | -187 |
Shares Outstanding | 38.30 | 37.40 | 36.80 | 35.60 | NA |
Book Value Per Share | 3.09 | 4.12 | 5.25 | 6.35 | 0.00 |
Fiscal Year End for Pulmonx Corporation falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 117 | 117 | 136 | 153 |
Receivables | NA | 12 | 10 | 9 | 8 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 17 | 16 | 16 | 16 |
Other Current Assets | NA | 4 | 4 | 4 | 4 |
Total Current Assets | NA | 150 | 147 | 164 | 181 |
Net Property & Equipment | NA | 4 | 4 | 4 | 4 |
Investments & Advances | NA | 17 | 27 | 17 | 7 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 2 | 2 | 2 | 2 |
Deposits & Other Assets | NA | 1 | 0 | 0 | 0 |
Total Assets | NA | 178 | 185 | 193 | 201 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 3 | 2 | 3 |
Current Portion Long-Term Debt | NA | 2 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 16 | 14 | 14 | 11 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 23 | 20 | 20 | 17 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 35 | 37 | 37 | 37 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 59 | 59 | 59 | 57 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 527 | 521 | 514 | 508 |
Retained Earnings | NA | -411 | -397 | -382 | -366 |
Other Equity | NA | 3 | 2 | 2 | 2 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 118 | 126 | 134 | 144 |
Total Liabilities & Shareholder's Equity | NA | 178 | 185 | 193 | 201 |
Total Common Equity | 0 | 118 | 126 | 134 | 144 |
Shares Outstanding | 38.50 | 38.30 | 38.00 | 37.70 | 37.70 |
Book Value Per Share | 0.00 | 3.09 | 3.31 | 3.55 | 3.82 |